Target intelligence / Profile preview

Translocating chain-associated membrane protein 1 (TRAM1)

Target
TRAM1
Molecular classification
Other (ER membrane multi-pass protein), TRAM/LAG1/CLN8 homology (TLC) domain-containing protein
01

Overview

Translocating chain-associated membrane protein 1 (TRAM1) is a multi-pass transmembrane protein localizing to the endoplasmic reticulum (ER) membrane and is a component of the protein translocation machinery. TRAM1 belongs to the TRAM/LAG1/CLN8 homology (TLC) domain protein family and is thought to play a supportive, rather than a receptor, role in the import of some precursor proteins into or across the ER membrane by influencing local lipid properties near the SEC61 channel but does not act as a selective substrate receptor[1][3]. TRAM1 associates closely with newly synthesized proteins early in their entry into or insertion into the ER and is required for efficient glycosylation and proper protein folding, as well as for ER-associated degradation during stress responses[1][3]. TRAM1-mediated processes are also implicated in certain genetic diseases and may influence viral immune evasion through ER-associated retrotranslocation mechanisms[3]. There are currently no known drugs that modulate TRAM1 directly, nor is it a typical therapeutic target such as a receptor, enzyme, transporter, or ion channel.

Other names
Translocation associated membrane protein 1TRAM1TRAMProtein TRAM1TRAMPPNAS8translocating chain-associated membrane protein 1translocating chain-associating membrane proteintranslocation-associating membrane protein 1
02

Biological functions

Protein translocation across the endoplasmic reticulum membraneRegulation of glycosylationFacilitates the positioning of nascent polypeptide chains at the SEC61 channelAssociates with nascent secretory and membrane proteinsParticipates in ER protein quality control and misfolded protein disposal during ER stressInteracts with sphingolipids/ceramides, possibly modulating the ER membrane environment
03

Disease associations

Ceroid lipofuscinosis, neuronal, 8, Northern epilepsy variantShort-rib thoracic dysplasia 9 with or without polydactylyOther (ER stress-related pathologies, viral immune escape)

Beyond the preview

Go deeper on Translocating chain-associated membrane protein 1 (TRAM1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Translocating chain-associated membrane protein 1 (TRAM1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call